Forest Investigative site 052 — Fayetteville, Tennessee

Forest Investigative site 052 is a clinical research site located in Fayetteville, Tennessee, United States 37334.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Forest Investigative site 052 has participated in 1 clinical trials.

Therapeutic areas: Stage 2 Diastolic Hypertension.

Sponsors: Forest Laboratories.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fayetteville

Browse all research sites in Tennessee · View every site in Fayetteville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forest Investigative site 052?

Forest Investigative site 052 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forest Investigative site 052 conducted?

Forest Investigative site 052 has 1 clinical trials on record. Their work covers Stage 2 Diastolic Hypertension.

Is Forest Investigative site 052 accredited by Crixeo Clinical Trials?

Forest Investigative site 052 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forest Investigative site 052?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.